These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 7986220)

  • 1. Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein response.
    Gabay C; Gay-Croisier F; Roux-Lombard P; Meyer O; Maineti C; Guerne PA; Vischer T; Dayer JM
    Arthritis Rheum; 1994 Dec; 37(12):1744-51. PubMed ID: 7986220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal IL-1 receptor antagonist production in patients with polymyositis and dermatomyositis.
    Son K; Tomita Y; Shimizu T; Nishinarita S; Sawada S; Horie T
    Intern Med; 2000 Feb; 39(2):128-35. PubMed ID: 10732829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of serum soluble tumour necrosis factor receptors in patients with polymyositis and dermatomyositis.
    Shimizu T; Tomita Y; Son K; Nishinarita S; Sawada S; Horie T
    Clin Rheumatol; 2000; 19(5):352-9. PubMed ID: 11055823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-35: A Serological Biomarker for Patients with Polymyositis/Dermatomyositis.
    Jiang Q; Li Y; Xia L; Shen H; Lu J
    J Interferon Cytokine Res; 2019 Nov; 39(11):720-725. PubMed ID: 31274382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of soluble ST2 and interleukin-33 in patients with dermatomyositis and polymyositis.
    Yuan L; Yao L; Zhao L; Xia L; Shen H; Lu J
    Clin Exp Rheumatol; 2013; 31(3):428-32. PubMed ID: 23485578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
    Gabay C; Cakir N; Moral F; Roux-Lombard P; Meyer O; Dayer JM; Vischer T; Yazici H; Guerne PA
    J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of Interleukin 21 and Interleukin 21 Receptor in Patients with Dermatomyositis and Polymyositis.
    Liu T; Hou Y; Dai TJ; Yan CZ
    Chin Med J (Engl); 2017 Sep; 130(17):2101-2106. PubMed ID: 28836555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum levels of neopterin in adult patients with polymyositis/dermatomyositis.
    Samsonov MY; Nassonov EL; Tilz GP; Geht BM; Demel U; Gurkina GT; Shtutman VZ; Guseva AG; Wachter H; Fuchs D
    Br J Rheumatol; 1997 Jun; 36(6):656-60. PubMed ID: 9236675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of cytokine inhibitors: a possible marker of disease activity in childhood dermatomyositis and polymyositis.
    Prieur AM; Dayer A; Roux-Lombard P; Dayer JM
    Clin Exp Rheumatol; 1997; 15(2):211-4. PubMed ID: 9196877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes.
    Mangge H; Kenzian H; Gallistl S; Neuwirth G; Liebmann P; Kaulfersch W; Beaufort F; Muntean W; Schauenstein K
    Arthritis Rheum; 1995 Feb; 38(2):211-20. PubMed ID: 7848311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease.
    Gono T; Kaneko H; Kawaguchi Y; Hanaoka M; Kataoka S; Kuwana M; Takagi K; Ichida H; Katsumata Y; Ota Y; Kawasumi H; Yamanaka H
    Rheumatology (Oxford); 2014 Dec; 53(12):2196-203. PubMed ID: 24970922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine antagonists in aged subjects and their relation with cellular immunity.
    Catania A; Airaghi L; Motta P; Manfredi MG; Annoni G; Pettenati C; Brambilla F; Lipton JM
    J Gerontol A Biol Sci Med Sci; 1997 Mar; 52(2):B93-7. PubMed ID: 9060965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.
    Kaneyama K; Segami N; Sun W; Sato J; Fujimura K
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):276-84. PubMed ID: 15716832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surfactant proteins-A and D as important serum markers for interstitial lung disease in patients with polymyositis or dermatomyositis].
    Chen F; Shu XM; Wang DX; Xie Y; Wang GC
    Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(31):2182-5. PubMed ID: 23158422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum interleukin-17A level is associated with disease activity of adult patients with dermatomyositis and polymyositis.
    Silva MG; Oba-Shinjo SM; Marie SKN; Shinjo SK
    Clin Exp Rheumatol; 2019; 37(4):656-662. PubMed ID: 30620283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced miR-146a Promotes REG3A Expression and Macrophage Migration in Polymyositis and Dermatomyositis.
    Jiang T; Huang Y; Liu H; Xu Q; Gong Y; Chen Y; Hu X; Han Z; Gao M
    Front Immunol; 2020; 11():37. PubMed ID: 32153557
    [No Abstract]   [Full Text] [Related]  

  • 17. [Measurement and clinical significance of serum monocyte chemoattractant protein-1 in patients with polymyosits/dermatomyosits].
    Chen F; Shu XM; Wang DX; Wang GC; Lu X
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):204-8. PubMed ID: 22516988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated Serum Levels of Soluble CD163 in Polymyositis and Dermatomyositis: Associated with Macrophage Infiltration in Muscle Tissue.
    Peng QL; Zhang YL; Shu XM; Yang HB; Zhang L; Chen F; Lu X; Wang GC
    J Rheumatol; 2015 Jun; 42(6):979-87. PubMed ID: 25877505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum levels of soluble vascular cell adhesion molecule-1 and soluble E-selectin in patients with polymyositis/dermatomyositis.
    Kubo M; Ihn H; Yamane K; Yazawa N; Kikuchi K; Soma Y; Tamaki K
    Br J Dermatol; 2000 Aug; 143(2):392-8. PubMed ID: 10951151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The IL-1 system in HIV infection: peripheral concentrations of IL-1beta, IL-1 receptor antagonist and soluble IL-1 receptor type II.
    Kreuzer KA; Dayer JM; Rockstroh JK; Sauerbruch T; Spengler U
    Clin Exp Immunol; 1997 Jul; 109(1):54-8. PubMed ID: 9218824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.